Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
By
Jeremy Veenstra-VanderWeele
28 January 2020 | 5 min read
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
By
Jeremy Veenstra-VanderWeele
10 June 2014 | 8 min read
Explore more from The Transmitter
When we sleep, our brain is filled with spontaneous neural activity. What is it doing?
Daniel Levenstein explains how internally generated brain activity during sleep shapes our cognition, and why NeuroAI is such a powerful approach to understanding the brain.
When we sleep, our brain is filled with spontaneous neural activity. What is it doing?
Daniel Levenstein explains how internally generated brain activity during sleep shapes our cognition, and why NeuroAI is such a powerful approach to understanding the brain.
By
Paul Middlebrooks
2 September 2026 | 96 min listen
Unconfounding genetic and environmental factors, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 31 August.
Unconfounding genetic and environmental factors, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 31 August.
By
Jill Adams
1 September 2026 | 2 min read
Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence
Two years into one of the most tumultuous tenures in U.S. federal funding, researchers outline how they are coping with ongoing changes and reflect on the impact these changes are having on the system more broadly.
Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence
Two years into one of the most tumultuous tenures in U.S. federal funding, researchers outline how they are coping with ongoing changes and reflect on the impact these changes are having on the system more broadly.
By
Emily Singer
28 August 2026 | 5 min read